CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer
Authors
AD Basso
B Leyland-Jones
+22 more
B Leyland-Jones
C Peng
CC Leow
Charles Henderson
Clifford Hudis
Cristina Saura
CS Gerbin
D Siegel
D Song
Eduardo Rodenas
J Baselga
Jill Goddard
Jose Baselga
Joyce O’Shaughnessy
JS Abramson
JT Garrett
Nancy U. Lin
R Bruno
Reshma Mahtani
S Modi
S Modi
Shanu Modi
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1007%2Fs10549-013-...
Last time updated on 05/06/2019